ONCY

#3426
Oncolytics Biotech Inc. - Common Stock
1.0 4 USD
+10.64%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
1.04
1.04
Faixa anual
0.33
1.51
Mudança diária
+10.64%
Mudança mensal
+14.29%
Mudança em 6 meses
+4.00%
Mudança anual
+173.68%
Fechamento anterior
0.9 4
Open
1.0 4
Mínimo
1.0 4
High
1.0 4
Volume
30
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor Q4, 24Q4, 25Q1, 26

Oncolytics Biotech Inc. - Common Stock

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

Notícias